Find a Trial

Trial Summary


Protocol No.C16-174
StatusOPEN TO ACCRUAL
Principal InvestigatorAdra, Nabil
ScopeNational
PhasePhase III
Age GroupAdult
TitleDORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
DescriptionThe purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.
Key EligibilityIn order to be eligible to take part in this trial, patients must meet the following criteria:
For a full list of participation criteria, please visit clinicaltrials.gov.
Applicable Disease SitesProstate
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactPhone: (317) 278-5632
    Email: iutrials@iu.edu